Enhancing the solubility of SARS-CoV-2 inhibitors to increase future prospects for clinical development

Despite the existence of vaccines for SARS-CoV-2, the constant evolution of new variants and the occurrence of breakthrough infections highlight the need for new and effective antiviral approaches. We have shown that lipopeptides designed to bind a conserved region on the SARS-CoV-2 spike protein ca...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Journal of virology Ročník 99; číslo 3; s. e0215924
Hlavní autoři:	Kuhn, Ariel J., Outlaw, Victor K., Marcink, Tara C., Yu, Zhen, Mears, Megan C., Cajimat, Maria N., Kreitler, Dale F., Cleven, Payton R., Mook, Jee Ching, Bente, Dennis A., Porotto, Matteo, Gellman, Samuel H., Moscona, Anne
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	United States American Society for Microbiology 18.03.2025
Témata:	antiviral Antiviral Agents - chemistry Antiviral Agents - pharmacology COVID-19 - virology COVID-19 Drug Treatment crystal structure Editor’s Pick heptad repeats Humans inhibitors lipopeptide Lipopeptides - chemistry Lipopeptides - pharmacology MATERIALS SCIENCE peptide design SARS-CoV-2 SARS-CoV-2 - drug effects Solubility Spike Glycoprotein, Coronavirus - antagonists & inhibitors Spike Glycoprotein, Coronavirus - chemistry Spike Glycoprotein, Coronavirus - metabolism Vaccines and Antiviral Agents viral fusion Virology Virus Internalization - drug effects inhibitors SARS-CoV-2 lipopeptide antiviral viral fusion crystal structure peptide design solubility heptad repeats
ISSN:	0022-538X, 1098-5514, 1098-5514
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!